Partial Remission of advanced Melanoma by Combination Therapy with Nivolumab and Trametinib after Treatment Failure with Ipilimumab plus Nivolumab

被引:0
|
作者
Zaremba, A. [1 ]
Chorti, E. [1 ]
Jockenhoefer, F. [1 ]
Albrecht, M. [1 ]
Placke, J. M. [1 ]
Knispel, S. [1 ]
Schadendorf, D. [1 ]
Hadaschik, E. [1 ]
Roesch, A. [1 ]
Ugurel, S. [1 ]
Zimmer, L. [1 ]
Livingstone, E. [1 ]
机构
[1] Univ Klinikum Essen, Dermatol, Essen, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P37
引用
收藏
页码:38 / 38
页数:1
相关论文
共 50 条
  • [1] Nivolumab plus ipilimumab in the treatment of advanced melanoma
    Tsai, Katy K.
    Daud, Adil I.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [2] Nivolumab plus ipilimumab in the treatment of advanced melanoma
    Katy K. Tsai
    Adil I. Daud
    Journal of Hematology & Oncology, 8
  • [3] Nivolumab plus Ipilimumab in Advanced Melanoma
    Wolchok, Jedd D.
    Kluger, Harriet
    Callahan, Margaret K.
    Postow, Michael A.
    Rizvi, Naiyer A.
    Lesokhin, Alexander M.
    Segal, Neil H.
    Ariyan, Charlotte E.
    Gordon, Ruth-Ann
    Reed, Kathleen
    Burke, Matthew M.
    Caldwell, Anne
    Kronenberg, Stephanie A.
    Agunwamba, Blessing U.
    Zhang, Xiaoling
    Lowy, Israel
    Inzunza, Hector David
    Feely, William
    Horak, Christine E.
    Hong, Quan
    Korman, Alan J.
    Wigginton, Jon M.
    Gupta, Ashok
    Sznol, Mario
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02): : 122 - 133
  • [4] Nivolumab plus Ipilimumab in Advanced Melanoma
    Santhosh, Akhil
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (12): : 1245 - 1246
  • [5] Ipilimumab plus nivolumab for advanced melanoma
    Hassel, Jessica C.
    LANCET ONCOLOGY, 2016, 17 (11): : 1471 - 1472
  • [6] Nivolumab and ipilimumab therapy for advanced melanoma
    Burki, Talha Khan
    LANCET ONCOLOGY, 2013, 14 (08): : E298 - E298
  • [7] Nivolumab in combination with ipilimumab for the treatment of melanoma
    Somasundaram, Rajasekharan
    Herlyn, Meenhard
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (10) : 1135 - 1141
  • [8] PKPD relationship of ipilimumab plus nivolumab combination in patients with advanced melanoma
    Goldwirt, L.
    Louveau, B.
    Liv, T.
    Baroudjian, B.
    Allayous, C.
    Da Meda, L.
    Delyon, J.
    Sauvageon, H.
    Lebbe, C.
    Mourah, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 38 - 38
  • [9] Dabrafenib plus trametinib versus nivolumab for advanced melanoma
    Lahoz, Daniela
    Reyes, Felipe
    Quirland, Camila
    MEDWAVE, 2023, 23 (01):